Merakris Sponsored Study Opens Door to Precision-Based Approaches to Wound Healing
September 13, 2022 06:00 ET
|
Merakris Therapeutics
RESEARCH TRIANGLE PARK, N.C., Sept. 13, 2022 (GLOBE NEWSWIRE) -- A recently published manuscript containing research sponsored, in part, by Merakris Therapeutics has opened the door to more...
Biotimize Announces the Opening of a Fundraising Round to Build the First Biological CDMO in Brazil
September 05, 2022 08:30 ET
|
Biotimize - Biotechnology as a Service
PIRACICABA, Brazil, Sept. 05, 2022 (GLOBE NEWSWIRE) -- Biotimize, a functional growth-stage biotechnology as a service (BaaS) company with a mission to transform lives through biotechnology, today...
BrightInsight Names Elisabethann Wright of Cooley to its Digital Health Advisory Council
August 30, 2022 03:00 ET
|
BrightInsight
SAN JOSE, Calif., Aug. 30, 2022 (GLOBE NEWSWIRE) -- BrightInsight, Inc., provider of the leading global platform for biopharma and medtech regulated digital health solutions, announced today the...
Societal CDMO Announces Signing of More Than $9 Million Sales and Purchase Agreement With David Weekley Homes for Excess Lakefront Land
August 16, 2022 07:00 ET
|
Societal CDMO, Inc.
Established Homebuilder to Purchase Approximately 121 Acres in Gainesville, Georgia, for Residential Development Proceeds from Sale to Strengthen Societal CDMO’s Corporate Balance Sheet Through...
Monopar Therapeutics Reports Second Quarter 2022 Financial Results and Recent Program Developments
August 11, 2022 08:05 ET
|
Monopar Therapeutics Inc.
WILMETTE, Ill., Aug. 11, 2022 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Monopar or the Company) (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing proprietary...
Societal CDMO Reports Second Quarter 2022 Financial Results
August 10, 2022 16:05 ET
|
Societal CDMO, Inc.
Recorded Q2 Revenue of $23.2 Million, a 29% Increase Compared to Prior Year Period Signed Multiple New Business Agreements Spanning Clinical Trial Support, Commercial Manufacturing and Packaging ...
Horizon Therapeutics Investor Alert: Kaplan Fox Investigates Potential Securities Fraud at Horizon Therapeutics Plc
August 03, 2022 15:58 ET
|
Kaplan Fox & Kilsheimer LLP
NEW YORK, Aug. 03, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Horizon Therapeutics plc ("Horizon Therapeutics” or...
Definitive Healthcare launches Passport Express to provide ready-to-use healthcare commercial intelligence for biopharma
July 26, 2022 08:30 ET
|
Definitive Healthcare Corp.
FRAMINGHAM, Mass., July 26, 2022 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced the general availability of...
Societal CDMO Announces Signing of Amendment to License and Supply Agreement With Lannett for Marketing of Verapamil PM and Verelan SR Products
July 12, 2022 07:00 ET
|
Societal CDMO, Inc.
Societal to Receive Greater Portion of Profit Sharing from Verapamil PM Product Sales Societal Awarded Potential New GMP Manufacturing Agreements for Multiple Additional Lannett Products SAN DIEGO...
Orange Grove Bio Provides Corporate Update Highlighting Key Leadership Appointments and Establishment of New Academic Collaboration
June 23, 2022 06:30 ET
|
Orange Grove Bio
John C. Byrd, M.D., Renowned Cancer Clinician and Researcher, Named Chair of Scientific Advisory Board New Collaboration with Northeast Ohio Medical University Further Demonstrates Company’s...